AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies.

Bioworld Financial Watch

| May 26, 2003 | COPYRIGHT 2003 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright
 
Manufacturing, Marketing And Distribution Agreements Between Biotech And 
Pharmaceutical Companies: March 25 -- May 21, 2003 # 
 
Biotech Co. *                   Pharma Co. 
(Country; Symbol)               (Country) 
 
Bioenvision Inc.                Penn Pharmaceutical 
(OTC BB: BIOV)                  Services Ltd. (UK) 
 
 
 
BioTime Inc.                    CJ Corp. 
(AMEX:BTX)                      (South Korea) 
 
 
 
 
 
 
 
Celgene Corp.                   GlaxoSmithKline plc 
(CELG)                          (UK) 
 
 
 
 
 
 
Eyetech Pharmaecuticals Inc. *  Pfizer Inc. 
 
 
 
Labopharm Inc.                  Gruppo Angelini 
(Canada; TSE:DDS)               (Italy) and Esteve 
                                SA (Spain) 
 
 
TolerRx Inc. *                  Laureate Pharma LP 
 
 
 
 
 
 
 
 
United Therapeutics Corp.       Caremark Inc. 
(UTHR) 
 
 
 
Biotech Co. *                   Product 
(Country; Symbol) 
 
Bioenvision Inc.                Clofarabine 
(OTC BB: BIOV) 
 
 
 
BioTime Inc.                    Hextend and PentaLyte 
(AMEX:BTX)                      blood plasma volume 
                                expanders 
 
 
 
 
 
 
Celgene Corp.                   Alkeran 
(CELG) 
 
 
 
 
 
 
Eyetech Pharmaecuticals Inc. *  Xalatan 
 
 
 
Labopharm Inc.                  A once-daily version of the 
(Canada; TSE:DDS)               analgesic tramadol 
 
 
 
TolerRx Inc. *                  Monoclonal antibodies 
 
 
 
 
 
 
 
 
United Therapeutics Corp.       Remodulin 
(UTHR) 
 
 
 
Biotech Co. *                   Terms/Details (Date) 
(Country; Symbol) 
 
Bioenvision Inc.                Penn Pharmaceutical will 
(OTC BB: BIOV)                  label, package, store and 
                                distribute clofarabine in 
                                Europe (5/15) 
 
BioTime Inc.                    Exclusive licensing agreement 
(AMEX:BTX)                      for CJ to manufacture and sell 
                                the expanders in South Korea 
                                for human therapeutic uses; 
                                ...
Related articles from newspapers, magazines, journals, and more
Chemo Kine Therapeutics Corp. To Appear on MN1.com.
Press release article from: M2 Presswire September 20, 2006 700+ words
...MN1.com: Chemo Kine Therapeutics Corp. To Appear on MN1...CEO, of Chemo Kine Therapeutics Corp. (OTC BB: CHKT), will be featured...at 2:30PM CDT. (OTC BB: CHKT) Chemokine Therapeutics Corp. is developing drugs...
AllPennyStocks.com spotlights Chemokine Therapeutics Corp.
Press release article from: M2 Presswire June 1, 2005 700+ words
...spotlight company Chemokine Therapeutics Corp. (TSX: CTI). Chemokine Therapeutics Corp. is a biotechnology...Venture, Nasdaq and OTC BB, and much more information...the report on Chemokine Therapeutics Corp. (TSX: CTI); the...
AllPennyStocks.com releases a special report on Chemokine Therapeutics Corp.
Press release article from: M2 Presswire June 14, 2005 700+ words
...report on Chemokine Therapeutics Corp.(C)1994-2005...discussing Chemokine Therapeutics Corp. (CTI: TSX...Venture, Nasdaq and OTC BB, and much more information...report on Chemokine Therapeutics Corp. (CTI:TSX...
Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine...
Press release article from: M2 Presswire January 9, 2008 700+ words
...Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT...beaconequityresearch.com Chemokine Therapeutics Corp. (OTCBB: CHKT...II Study Chemokine Therapeutics Corp. (the "Company...Acro, Inc. (OTC BB:ACRI), a leading...
Stem Cell Therapeutics Corp.: Dr. Alan Moore Will Present the Company's Brain...
News wire article from: Marketwire Canada October 2, 2009 700+ words
...Marketwire via COMTEX) -- Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) announced...grow their businesses. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a public biotechnology company...
Stem Cell Therapeutics Corp. Announces Dr. V. Wee Yong's Presentation at the...
News wire article from: Marketwire Canada September 11, 2009 700+ words
...Marketwire via COMTEX) -- Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) today...throughout the world. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a public biotechnology company...
Stem Cell Therapeutics Corp. to Present at BioFinance 2005.
Press release article from: PR Newswire May 12, 2005 700+ words
...Tucker, President and CEO of Stem Cell Therapeutics Corp. ("SCT"), will present a corporate...Trinity V conference room. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a biotechnology company focused...
Stem Cell Therapeutics Corp. and Medicon A/S Initiate Dosing of Patients in...
Press release article from: PR Newswire Europe November 29, 2005 700+ words
...Venture Exchange: SSS Stem Cell Therapeutics Corp. ("SCT") is pleased to announce...point in the evolution of Stem Cell Therapeutics Corp. from a pre-clinical research...thorough QT-trials. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA